tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ARGX Stock Latest News

Argenx price target raised to $925 from $830 at JPMorgan
The FlyArgenx price target raised to $925 from $830 at JPMorgan
14h ago
ARGX
Promising Outlook for arGEN X: Robust Sales Projections and Strategic Expansion Drive Positive Risk-Reward Balance
PremiumRatings
Promising Outlook for arGEN X: Robust Sales Projections and Strategic Expansion Drive Positive Risk-Reward Balance
15h ago
ARGX
Denali says chief medical officer Carole Ho to depart to join Eli Lilly
PremiumThe Fly
Denali says chief medical officer Carole Ho to depart to join Eli Lilly
1d ago
LLY
ARGX
Argenx announces Health Canada approval of Vyvgart in CIDP
PremiumThe Fly
Argenx announces Health Canada approval of Vyvgart in CIDP
2d ago
ARGX
Argenx price target raised to $930 from $820 at Piper Sandler
PremiumThe Fly
Argenx price target raised to $930 from $820 at Piper Sandler
4d ago
ARGX
Argenx price target raised to EUR 675 from EUR 655 at Deutsche Bank
PremiumThe FlyArgenx price target raised to EUR 675 from EUR 655 at Deutsche Bank
4d ago
ARGX
Argenx price target raised to $950 from $918 at Truist
Premium
The Fly
Argenx price target raised to $950 from $918 at Truist
6d ago
ARGX
Argenx’s Earnings Call: Record Growth and Strategic Success
Premium
Company Announcements
Argenx’s Earnings Call: Record Growth and Strategic Success
7d ago
ARGX
Argenx price target raised to $910 from $775 at Evercore ISI
PremiumThe Fly
Argenx price target raised to $910 from $775 at Evercore ISI
7d ago
ARGX
Argenx price target raised to $924 from $788 at Baird
PremiumThe Fly
Argenx price target raised to $924 from $788 at Baird
8d ago
ARGX
Argenx price target raised to $915 from $774 at H.C. Wainwright
PremiumThe Fly
Argenx price target raised to $915 from $774 at H.C. Wainwright
8d ago
ARGX
Argenx Reports Strong Q3 2025 Financial Performance
PremiumCompany Announcements
Argenx Reports Strong Q3 2025 Financial Performance
8d ago
ARGX
Argenx Se: Strong Financial Performance and Promising Pipeline Drive Buy Rating
PremiumRatingsArgenx Se: Strong Financial Performance and Promising Pipeline Drive Buy Rating
8d ago
ARGX
Argenx SE Reports Strong Q3 2025 Financial Results and Strategic Advances
Premium
Company Announcements
Argenx SE Reports Strong Q3 2025 Financial Results and Strategic Advances
9d ago
6K
ARGX
Argenx Se: Strong Financial Performance and Strategic Growth Drive Buy Rating
Premium
Ratings
Argenx Se: Strong Financial Performance and Strategic Growth Drive Buy Rating
9d ago
ARGX
Argenx reports Q3 EPS $5.18, consensus $3.56
PremiumThe Fly
Argenx reports Q3 EPS $5.18, consensus $3.56
9d ago
ARGX
Argenx SE Highlights VYVGART’s Efficacy in Treating Myasthenia Gravis
PremiumCompany Announcements
Argenx SE Highlights VYVGART’s Efficacy in Treating Myasthenia Gravis
9d ago
6K
ARGX
Argenx says Phase 3 myasthenia gravis study met primary endpoint
PremiumThe Fly
Argenx says Phase 3 myasthenia gravis study met primary endpoint
9d ago
ARGX
Argenx’s New Study on Efgartigimod IV: A Potential Game-Changer for Pediatric ITP Treatment
PremiumCompany Announcements
Argenx’s New Study on Efgartigimod IV: A Potential Game-Changer for Pediatric ITP Treatment
11d ago
ARGX
Argenx price target raised to $1,041 from $845 at Citi
PremiumThe FlyArgenx price target raised to $1,041 from $845 at Citi
16d ago
ARGX
Argenx price target raised to $942 from $887 at BofA
Premium
The Fly
Argenx price target raised to $942 from $887 at BofA
19d ago
ARGX
Argenx’s Vyvgart: Strong Performance and Growth Potential Drive Buy Rating
Premium
Ratings
Argenx’s Vyvgart: Strong Performance and Growth Potential Drive Buy Rating
19d ago
ARGX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >